Sanofi to pay Regeneron up to $8 billion to add new antibodies under Dupixent partnership ↧ ↧ Sanofi to pay Regeneron up to $8 billion to add new antibodies unde... Sanofi said on Thursday it would pay US partner Regeneron $1 billion upfront and up to $7 billion in milestone payments to bring four new antibodies under the partnership behind their blockbuster eczema drug Dupixent, which sent the French drugmaker's shares 2% higher in early trading.
published
Sanofi to pay Regeneron up to $8 billion to add new antibodies under Dupixent partnership ↧
Open the original public source →
Latest documented BWB result
$NCPL · $GCDT · $SUNE market result
Here is my September recap 💥 Entry top percentage of move For sure i didn’t hold the full move on all of them, and for sure i got hit with a lot of losses, but i always manage to have a plan, stick to it, minimize losse…
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.